STING1 and non-small cell lung carcinoma: More importantly, STING can be activated by cGAS through the second messenger cGAMP of cyclic dinucleotide (CDN) [18].The established cGAS-STING pathway plays an important role in connecting anti-cancer innate immunity and adaptive immunity [44], thereby offering a novel strategy for the treatment of NSCLC.